Original article
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
Takanori Suzukia, Akihiro Tamorib,c, Kentaro Matsuuraa,
, Takako Inoued, Shigeru Kusumotoe,f, Shinya Hagiwarae,f, Haruka Sagig, Atsushi Kanekog, Shuko Murakamih, Hayato Kawamraa, Kei Fujiwaraa, Katsumi Aoyagig,i, Masaru Enomotob, Ritsuzo Kozukab, Hiromi Kataokaa, Yasuhito Tanakaj
Corresponding author
a Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
b Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
c Department of Hepatology, Kashiwara Municipal Hospital, Kashiwara, Japan
d Department of Clinical Laboratory Medicine, Nagoya City University Hospital, Nagoya, Japan
e Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
f Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
g Fujirebio Inc., Hachioji, Tokyo, Japan
h Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
i Advanced Life Science Institute, Inc., Hachioji, Tokyo, Japan
j Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
Ver más
